Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women-Reference-Cited by-同舟云学术

Efficacy of Single-Dose Human Papillomavirus Vaccination among Young African Women

Published:2022-04-26 Issue:5 Volume:1 Page:
ISSN:2766-5526
Container-title:NEJM Evidence
language:en
Short-container-title:NEJM Evidence

Author:

Barnabas Ruanne V.¹²,Brown Elizabeth R.³⁴⁵,Onono Maricianah A.⁶,Bukusi Elizabeth A.⁶⁷⁸,Njoroge Betty⁹,Winer Rachel L.¹⁰,Galloway Denise A.⁴¹¹,Pinder Leeya F.⁸¹¹,Donnell Deborah⁵⁷,Wakhungu Imelda⁶,Congo Ouma⁶,Biwott Charlene⁹,Kimanthi Syovata⁹,Oluoch Lynda⁹,Heller Kate B.⁷,Leingang Hannah⁷,Morrison Susan⁷,Rechkina Elena⁷,Cherne Stephen¹²,Schaafsma Torin T.⁷,McClelland R. Scott⁷¹⁰¹³,Celum Connie⁷¹⁰¹³,Baeten Jared M.⁷¹⁰¹³¹⁴,Mugo Nelly⁷⁹

Affiliation:

1. Division of Infectious Diseases, Massachusetts General Hospital, Boston

2. Harvard Medical School, Boston

3. Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle

4. Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle

5. Department of Biostatistics, University of Washington, Seattle

6. Center for Microbiology Research, Kenya Medical Research Institute, Nairobi

7. Department of Global Health, University of Washington, Seattle

8. Department of Obstetrics and Gynecology, University of Washington, Seattle

9. Center for Clinical Research, Kenya Medical Research Institute, Nairobi

10. Department of Epidemiology, University of Washington, Seattle

11. Human Biology Division, Fred Hutchinson Cancer Research Center, Seattle

12. Department of Pathology, University of Washington, Seattle

13. Division of Allergy and Infectious Diseases, University of Washington, Seattle

14. Gilead Sciences, Foster City, CA

Publisher

Massachusetts Medical Society

Reference35 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. World Health Organization. A global strategy for elimination of cervical cancer as a public health problem. 2020 (https://www.who.int/publications/i/item/9789240014107).

3. Cancer Council. Australia set to eliminate cervical cancer by 2035. 2018 (https://www.cancer.org.au/news/media-releases/australia-set-to-eliminate-cervical-cancer-by-2035.html).

4. A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women

5. A Controlled Trial of a Human Papillomavirus Type 16 Vaccine

Cited by 65 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Global perspectives of determinants influencing HPV vaccine introduction and scale-up in low- and middle-income countries;PLOS ONE;2024-01-16

2. Durability of single-dose HPV vaccination in young Kenyan women: randomized controlled trial 3-year results;Nature Medicine;2023-12

3. Cost-effectiveness of human papillomavirus (HPV) vaccination in Burkina Faso: a modelling study;BMC Health Services Research;2023-12-01

4. Is immunotherapy a potential game changer in managing human papillomavirus (HPV) infection and intraepithelial neoplasia?;Tumour Virus Research;2023-12

5. Treatment of Cervical Precancers is the Major Remaining Challenge in Cervical Screening Research;Cancer Prevention Research;2023-12-01